DaRT radiation device study for treating tumors
Part of Cancer clinical trials.
This study tests a radiation-emitting device (called DaRT) for treating cancer tumors. It may help shrink or control malignant tumors and researchers will check safety and response to the treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have a cancer diagnosis
- Your tumor is 7 centimeters or smaller at its longest point
- You’re expected to live more than 6 months
- You can sign an informed consent form (or your legal helper can)
- If you could get pregnant: you must have a negative pregnancy test and use birth control during the study and for 3 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a radiation-emitting device (DaRT) to treat certain cancers on the skin, in the mouth, or in superficial soft tissues. You may qualify if you have a confirmed malignant tumor, enough body strength for treatment, and blood tests and pregnancy status that meet safety limits.
This trial tests a targeted radiation device (DaRT seeds) to treat certain cancers on the skin, in the mouth, or in superficial soft tissue. It may help when standard treatment (like surgery or regular radiation/chemo) hasn’t worked, isn’t safe, or isn’t wanted.
This trial tests a new type of radiation using tiny alpha-emitting seeds placed directly into the tumor. It is for people whose prostate cancer came back in the gland after initial treatment but hasn't spread elsewhere.
This trial tests whether a targeted internal radiation treatment (DaRT) combined with pembrolizumab (an immune therapy) can shrink recurrent or metastatic head and neck squamous cell cancer that cannot be fully removed with surgery. It may help by making cancer more visible to the immune system while delivering localized radiation to a tumor area.
This trial tests a treatment that places tiny radiation “seeds” inside/near the chest tumor to treat recurrent lung cancer. It may help people whose cancer has come back and can be safely reached by the radiation device.
This trial studies DaRT, a treatment given before surgery, to improve outcomes for certain oral cavity squamous cell cancers that can be fully removed. You would be carefully selected using scans and tests to make sure the cancer is in the right place and you can safely receive the treatment.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.